Literature DB >> 26200502

Autosomal Recessive Bestrophinopathy Is Not Associated With the Loss of Bestrophin-1 Anion Channel Function in a Patient With a Novel BEST1 Mutation.

Adiv A Johnson1, Lori A Bachman1, Benjamin J Gilles1, Samuel D Cross1, Kimberly E Stelzig2, Zachary T Resch2, Lihua Y Marmorstein1, Jose S Pulido3, Alan D Marmorstein1.   

Abstract

PURPOSE: Mutations in BEST1, encoding bestrophin-1 (Best1), cause autosomal recessive bestrophinopathy (ARB). Encoding bestrophin-1 is a pentameric anion channel localized to the basolateral plasma membrane of the RPE. Here, we characterize the effects of the mutations R141H (CGC > CAC) and I366fsX18 (c.1098_1100+7del), identified in a patient in our practice, on Best1 trafficking, oligomerization, and channel activity.
METHODS: Currents of Cl- were assessed in transfected HEK293 cells using whole-cell patch clamp. Best1 localization was assessed by confocal microscopy in differentiated, human-induced pluripotent stem cell-derived RPE (iPSC-RPE) cells following expression of mutants via adenovirus-mediated gene transfer. Oligomerization was evaluated by coimmunoprecipitation in iPSC-RPE and MDCK cells.
RESULTS: Compared to Best1, Best1 I366fsX18 currents were increased while Best1 R141H Cl- currents were diminished. Coexpression of Best1 R141H with Best1 or Best1 I366fsX18 resulted in rescued channel activity. Overexpressed Best1, Best1 R141H, and Best1 I366fsX18 were all properly localized in iPSC-RPE cells; Best1 R141H and Best1 I366fsX18 coimmunoprecipitated with endogenous Best1 in iPSC-RPE cells and with each other in MDCK cells.
CONCLUSIONS: The first 366 amino acids of Best1 are sufficient to mediate channel activity and homo-oligomerization. The combination of Best1 and Best1 R141H does not cause disease, while Best1 R141H together with Best1 I366fsX18 causes ARB. Since both combinations generate comparable Cl- currents, this indicates that ARB in this patient is not caused by a loss of channel activity. Moreover, Best1 I366fsX18 differs from Best1 in that it lacks most of the cytosolic C-terminal domain, suggesting that the loss of this region contributes significantly to the pathogenesis of ARB in this patient.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26200502      PMCID: PMC4515977          DOI: 10.1167/iovs.15-16910

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  49 in total

1.  Identification of the gene responsible for Best macular dystrophy.

Authors:  K Petrukhin; M J Koisti; B Bakall; W Li; G Xie; T Marknell; O Sandgren; K Forsman; G Holmgren; S Andreasson; M Vujic; A A Bergen; V McGarty-Dugan; D Figueroa; C P Austin; M L Metzker; C T Caskey; C Wadelius
Journal:  Nat Genet       Date:  1998-07       Impact factor: 38.330

2.  Structure and insights into the function of a Ca(2+)-activated Cl(-) channel.

Authors:  Veronica Kane Dickson; Leanne Pedi; Stephen B Long
Journal:  Nature       Date:  2014-10-22       Impact factor: 49.962

3.  A short motif in the C-terminus of mouse bestrophin 3 [corrected] inhibits its activation as a Cl channel.

Authors:  Zhiqiang Qu; Yuanyuan Cui; Criss Hartzell
Journal:  FEBS Lett       Date:  2006-03-20       Impact factor: 4.124

4.  Bestrophin 1 is indispensable for volume regulation in human retinal pigment epithelium cells.

Authors:  Andrea Milenkovic; Caroline Brandl; Vladimir M Milenkovic; Thomas Jendryke; Lalida Sirianant; Potchanart Wanitchakool; Stephanie Zimmermann; Charlotte M Reiff; Franziska Horling; Heinrich Schrewe; Rainer Schreiber; Karl Kunzelmann; Christian H Wetzel; Bernhard H F Weber
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-04       Impact factor: 11.205

5.  Expression of bestrophin-1, the product of the VMD2 gene, modulates voltage-dependent Ca2+ channels in retinal pigment epithelial cells.

Authors:  Rita Rosenthal; Benjamin Bakall; Tyson Kinnick; Neal Peachey; Sönke Wimmers; Claes Wadelius; Alan Marmorstein; Olaf Strauss
Journal:  FASEB J       Date:  2005-11-10       Impact factor: 5.191

6.  Autosomal recessive best vitelliform macular dystrophy: report of a family and management of early-onset neovascular complications.

Authors:  Alessandro Iannaccone; Natalie C Kerr; Tyson R Kinnick; Jorge I Calzada; Edwin M Stone
Journal:  Arch Ophthalmol       Date:  2011-02

7.  Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best's disease).

Authors:  A Marquardt; H Stöhr; L A Passmore; F Krämer; A Rivera; B H Weber
Journal:  Hum Mol Genet       Date:  1998-09       Impact factor: 6.150

8.  The light peak of the electroretinogram is dependent on voltage-gated calcium channels and antagonized by bestrophin (best-1).

Authors:  Lihua Y Marmorstein; Jiang Wu; Precious McLaughlin; John Yocom; Mike O Karl; Rudgar Neussert; Soenke Wimmers; J Brett Stanton; Ronald G Gregg; Olaf Strauss; Neal S Peachey; Alan D Marmorstein
Journal:  J Gen Physiol       Date:  2006-05       Impact factor: 4.086

9.  In-depth characterisation of Retinal Pigment Epithelium (RPE) cells derived from human induced pluripotent stem cells (hiPSC).

Authors:  Caroline Brandl; Stephanie J Zimmermann; Vladimir M Milenkovic; Sibylle M G Rosendahl; Felix Grassmann; Andrea Milenkovic; Ute Hehr; Marianne Federlin; Christian H Wetzel; Horst Helbig; Bernhard H F Weber
Journal:  Neuromolecular Med       Date:  2014-05-07       Impact factor: 3.843

10.  Bestrophin-1 influences transepithelial electrical properties and Ca2+ signaling in human retinal pigment epithelium.

Authors:  Alan D Marmorstein; Tyson R Kinnick; J Brett Stanton; Adiv A Johnson; Ronald M Lynch; Lihua Y Marmorstein
Journal:  Mol Vis       Date:  2015-04-01       Impact factor: 2.367

View more
  20 in total

Review 1.  Bestrophin 1 and retinal disease.

Authors:  Adiv A Johnson; Karina E Guziewicz; C Justin Lee; Ravi C Kalathur; Jose S Pulido; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Prog Retin Eye Res       Date:  2017-01-30       Impact factor: 21.198

Review 2.  Using induced pluripotent stem cells to understand retinal ciliopathy disease mechanisms and develop therapies.

Authors:  David A Parfitt; Amelia Lane; Conor Ramsden; Katarina Jovanovic; Peter J Coffey; Alison J Hardcastle; Michael E Cheetham
Journal:  Biochem Soc Trans       Date:  2016-10-15       Impact factor: 5.407

Review 3.  BEST1: the Best Target for Gene and Cell Therapies.

Authors:  Tingting Yang; Sally Justus; Yao Li; Stephen H Tsang
Journal:  Mol Ther       Date:  2015-09-21       Impact factor: 11.454

4.  Vitelliform dystrophies: Prevalence in Olmsted County, Minnesota, United States.

Authors:  Lauren A Dalvin; Jose S Pulido; Alan D Marmorstein
Journal:  Ophthalmic Genet       Date:  2016-04-27       Impact factor: 1.803

5.  Visual Acuity and Foveal Structure in Eyes with Fragmented Foveal Avascular Zones.

Authors:  Rachel E Linderman; Jenna A Cava; Alexander E Salmon; Toco Y Chui; Alan D Marmorstein; Brandon J Lujan; Richard B Rosen; Joseph Carroll
Journal:  Ophthalmol Retina       Date:  2019-11-22

6.  Identification of Novel and Recurrent Disease-Causing Mutations in Retinal Dystrophies Using Whole Exome Sequencing (WES): Benefits and Limitations.

Authors:  Amit Tiwari; Johannes Lemke; Janine Altmueller; Holger Thiele; Esther Glaus; Johannes Fleischhauer; Peter Nürnberg; John Neidhardt; Wolfgang Berger
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

7.  Retinitis pigmentosa associated with a mutation in BEST1.

Authors:  Lauren A Dalvin; Jackson E Abou Chehade; John Chiang; Josefine Fuchs; Raymond Iezzi; Alan D Marmorstein
Journal:  Am J Ophthalmol Case Rep       Date:  2016-03-30

8.  Bestrophin 1 gene analysis and associated clinical findings in a Chinese patient with Best vitelliform macular dystrophy.

Authors:  Ying Lin; Tao Li; Hongbin Gao; Yu Lian; Chuan Chen; Yi Zhu; Yonghao Li; Bingqian Liu; Wenli Zhou; Hongye Jiang; Xialin Liu; Xiujuan Zhao; Xiaoling Liang; Chenjin Jin; Xinhua Huang; Lin Lu
Journal:  Mol Med Rep       Date:  2017-08-04       Impact factor: 2.952

Review 9.  Induced Pluripotent Stem Cell Therapies for Degenerative Disease of the Outer Retina: Disease Modeling and Cell Replacement.

Authors:  Valentina Di Foggia; Priyanka Makwana; Robin R Ali; Jane C Sowden
Journal:  J Ocul Pharmacol Ther       Date:  2016-03-30       Impact factor: 2.671

10.  Restoration of mutant bestrophin-1 expression, localisation and function in a polarised epithelial cell model.

Authors:  Carolina Uggenti; Kit Briant; Anne-Kathrin Streit; Steven Thomson; Yee Hui Koay; Richard A Baines; Eileithyia Swanton; Forbes D Manson
Journal:  Dis Model Mech       Date:  2016-08-12       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.